Analysis of Chronic Disease Direct Cost at Public Primary Health Cares in Indonesia

Authors

  • Indriyati Hadi Sulistyaningrum Doctoral Student, Faculty of Pharmacy, Gadjah Mada University, Yogyakarta, Indonesia and Pharmacy Department, Medical Faculty, Islam Sultan Agung University, Semarang, Indonesia
  • Susi Ari Kristina Department of Pharmaceutics, Faculty of Pharmacy, Gadjah Mada University, Yogyakarta, Indonesia
  • Ali Ghufron Mukti Faculty of Medicine, Nursing, and Public Health, Gadjah Mada University, Yogyakarta, Indonesia
  • - Satibi Department of Pharmaceutics, Faculty of Pharmacy, Gadjah Mada University, Yogyakarta, Indonesia

DOI:

https://doi.org/10.3329/bjms.v20i4.54131

Keywords:

Universal Health Coverage; Chronic Disease; Drug Cost; Capitation; Indonesia

Abstract

Objectives: This study aims to analyze the of drug costs for patients with chronic diseases in the capitation system in public primary health cares (Public PHCs).

Materials and Methods: This research is a quantitative study with an observational cross-sectional approach at 16 Public PHCs. Data collection used the retrospective method. The total sample was 293 outpatients in 2016.

Results: The results showed that 63% of patients are female. The most patients are aged between 56-65 years (37%). The average drug cost for patients receiving more than 3 types of drugs is IDR 7,726. The biggest drug cost is patients with DM type 2 with which the average cost is IDR 7.400. And the metformin treatment is 17 (6%) patients with the cost IDR 4,500,-. Chi-square analysis shows that the quantity of drug items, type of disease and prescriptions there are have significant effect on drug cost (p-value <0.05). However, gender and age group there are no significant effect on drug cost (p-value >0.05). Drug prescriptions are an important component in managing chronic diseases patients. Prescribing costs provide important information in the sustainability of the management of chronic disease programs.

Conclusion: This study recommends that the prolanis policy in public PHCs is focused on the elderly age group patients and female group.

Bangladesh Journal of Medical Science Vol.20(4) 2021 p.762-767

Downloads

Download data is not yet available.
Abstract
33
PDF
48

Downloads

Published

2021-06-18

How to Cite

Sulistyaningrum, I. H., Kristina, S. A., Mukti, A. G., & Satibi, .-. (2021). Analysis of Chronic Disease Direct Cost at Public Primary Health Cares in Indonesia. Bangladesh Journal of Medical Science, 20(4), 762–767. https://doi.org/10.3329/bjms.v20i4.54131

Issue

Section

Original Articles